Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Pharmacielo Ltd V.PCLO

Alternate Symbol(s):  PCLOF

PharmaCielo Ltd. is a Canada-based company with a focus on ethical and sustainable processing and supplying of all natural, pharmaceutical-grade medical cannabis products to channel distributors. The Company has two subsidiaries, PharmaCielo Colombia Holdings S.A.S. (PharmaCielo Colombia) and Ubiquo Telemedicina S.A.S. (Ubiquo). PharmaCielo Colombia cultivates and processes the Company’s all-natural cannabis into standardized, medicinal-grade oil extracts and related products. In Colombia, PharmaCielo Colombia is a licensed cultivator, producer, and distributor of both TetraHydroCannabinol (THC) and Cannabidiol (CBD) medical cannabis for use in Colombia, international export, and research purposes. Ubiquo is a knowledge management and medical consultation system that focuses on creating access to healthcare for Colombians. Ubiquo is a technology platform and a user interface that allows doctors and patients to communicate. Ubiquo is used as a communication tool.


TSXV:PCLO - Post by User

Bullboard Posts
Comment by Dmajormineron Oct 03, 2019 10:39pm
211 Views
Post# 30194807

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Misleading news release

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Misleading news release
Why don't you give the actual true picture instead of trying to put lipstick on this pig. I was filled in on the facility from a freind who has seen just about everything in the cannabis space. He said its not even close to top 25 in the world and is still a work in progress. There are facilities out there that make this one look like a joke.  Medipharm, Valens to name a few.  A few weeks....actually your looking at sometime in November.  Then there is setup and testing.  It wont be a properly functioning facility until next year according to him. 

Then there is this flakey Creso deal .  Pharmacielo puposely stopped trading in Creso even though the merger is now delayed till a late November closing.  All those Aussie shareholders who wnted to dump got blindsided and are quite pissed about it. Basically PCLO denied them an out. Very unhappy shareholder base now in that camp. PCLO didnt want the addittional pressure on the share price leading into the upcoming financing. Of course the delays are also bad for PCLO as the miniscule revenues fro Creso dont go to PCLO.  Essentially no revs this year unless you include whatever they can gereate from that founder owned U.S. shell they created. Next year looks very iffy as well . No way they hit GMP's targets.

I saw several other facilities. Both my freind and I agree that Khiron in particular is far ahead of Pharmacielo. Its not a contest though. Most guys didn't even bother with Pharmacielo as they are perceived as shady and manipulated. Everyone knows the story of the money (millions)  they paid to the Swiss traders to wash stock. Just a matter of time before the regulators catch them, 

Overall , all these Columbian startups are in trouble as the huge glut of extract oil out there is driving down prices and margins in a huge way, The two big drivers of the glut are the banning of most vape pens as well as regulatory delays in many edible products.  Freind also said that PLCO doesnt have much cost advantage over lots of other large indooor as well as a massier number of outdoor facilities in the US and other locations around the world. PCLO is at more like ,.25 -.35 cents a gram all in which is not much different than others.  Its certainly not the glorious advantage that Pharmacielo is telling you. Distribution networks come at large costs.

Bottom line is this is no magical story.  Freind thinks its a huge short and he really knows his stuff. Hope you all didnt mortgage the house or bet your life savings on this because its not going to be a happy ride down for you.


Bullboard Posts